Basel, North West Switzerland
Web: Roche
Location: Basel
Medicine Jan 10
Roche commences tender offer for all shares of Ignyta, Inc. for US$ 27.00 per share in cash Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Ignyta, Inc.
Medicine Jan 4

Roche launches the cobas Plasma Separation Card to increase access to HIV testing for patients living in remote areas.

Medicine Dec 12

Roche announces phase III data showing Venclexta/Venclyxto plus MabThera/Rituxan reduced the risk of disease progression or death by 83% compared to a standard of care regimen in previously treated chronic lymphocytic leukaemia.

Medicine Dec 21

European Commission approves Roche's Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer.

Medicine Dec 7

Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer.

Medicine Nov 7

FDA approves Zelboraf (vemurafenib) for Erdheim-Chester disease with BRAF V600 mutation.

Job Offers
» Job Offers: Roche

Last job offers

website preview